Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 465M | 475M | 603M | 432M | 187M | 483M |
| Cost of revenue | 418M | 452M | 513M | 389M | 166M | 400M |
| Gross profit | 47M | 23M | 89M | 43M | 21M | 83M |
| Research and development | 21M | 19M | 26M | 22M | 17M | 15M |
| Selling, general and administrative | 37M | 42M | 36M | 41M | 37M | 45M |
| Pre-tax income | −28M | −70M | 11M | −44M | −59M | 5M |
| Income tax | 2M | −8M | 5M | −2M | −2M | 4M |
| Net income | −21M | −45M | 6M | −31M | −41M | 785,000 |
| Earnings per share | −0.16 | −0.34 | 0.05 | −0.24 | −0.32 | 0.01 |
| Earnings per share, diluted | −0.16 | −0.34 | 0.01 | −0.24 | −0.32 | 0.00 |
| Weighted average shares | 133M | 132M | 131M | 130M | 129M | 128M |
| Weighted average shares, diluted | 133M | 132M | 184M | 130M | 129M | 184M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 387M | 453M | 691M | 436M | 569M | 654M | 519M | 513M |
| Receivables | 180M | 289M | 273M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | −227M | — | — | −211M | — |
| Depreciation and amortisation | 4M | 9M | 4M | 3M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 153M |
| 149M |
| 147M |
| 216M |
| 93M |
| Inventory | 764M | 541M | 455M | 654M | 698M | 543M | 183M | 470M |
| Current assets | 2.08B | 1.99B | 2.06B | 1.85B | 2.03B | 1.98B | 1.68B | 1.50B |
| Property, plant and equipment | 42M | 46M | 50M | 46M | 20M | 19M | 15M | 14M |
| Goodwill | 29M | 29M | 29M | 29M | 27M | 26M | 27M | 26M |
| Total assets | 2.35B | 2.27B | 2.36B | 2.08B | 2.27B | 2.21B | 1.90B | 1.69B |
| Current liabilities | 1.45B | 1.34B | 1.37B | 1.12B | 1.35B | 1.26B | 1.26B | 1.12B |
| Short-term debt | — | — | 0 | 0 | 0 | 0 | 30M | 54M |
| Long-term debt | — | — | — | — | — | — | 0 | 0 |
| Total liabilities | 1.89B | 1.78B | 1.81B | 1.55B | 1.77B | 1.68B | 1.30B | 1.15B |
| Equity | 368M | 388M | 430M | 407M | 499M | 529M | 607M | 538M |
| 4M |
| 4M |
| Share-based compensation | — | 5M | — | — | 5M | — |
| Capital expenditure | — | 6M | — | — | 2M | — |
| Investing cash flow | — | −9M | — | — | −5M | — |
| Financing cash flow | — | −2M | — | — | 361M | — |